Abstract
Previous studies have shown that the cell cycle-regulated B-myb promoter contains a conserved E2F binding site that is critical for repressing transcription in quiescent cells. To investigate its significance for permanent promoter silencing, we have inactivated this binding site in the mouse genome. Mice homozygous for the mutant B-mybmE2F allele were fully viable, however, B-myb transcription was derepressed during quiescence in mouse embryo fibroblasts (MEFs) derived from mutant animals. Moreover, it was found that mutation of the E2F site resulted in abnormal maintenance of B-myb expression in senescent MEFs and in differentiated brain tissue. These findings therefore reveal a direct and primary role for repressive E2F complexes in silencing gene expression in post-mitotic cells. Analysis of histone modifications at the promoter showed that histone H3 lysine 9 was constitutively acetylated throughout the cell cycle in homozygous mutant MEFs. This mouse system is the first description of an E2F site mutation in situ and will facilitate the study of E2F function in vivo.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Attwooll C, Lazzerini Denchi E, Helin K . (2004). The E2F family: specific functions and overlapping interests. EMBO J 23: 4709–4716.
Bennett JD, Farlie P, Watson RJ . (1996). E2F binding is required but not sufficient for repression of B-Myb transcription in quiescent fibroblasts. Oncogene 13: 1073–1082.
Catchpole S, Tavner F, Le Cam L, Sardet C, Watson RJ . (2002). A B-myb promoter corepressor site facilitates in vivo occupation of the adjacent E2F site by p107 × E2F and p130 × E2F complexes. J Biol Chem 277: 39015–39024.
Cobrinik D . (2005). Pocket proteins and cell cycle control. Oncogene 24: 2796–2809.
Gaubatz S, Lindeman GJ, Ishida S, Jakoi L, Nevins JR, Livingston DM et al. (2000). E2F4 and E2F5 play an essential role in pocket protein-mediated G1 control. Mol Cell 6: 729–735.
Hurford RK, Cobrinik D, Lee M-H, Dyson N . (1997). pRb and p107/p130 are required for the regulated expression of different sets of E2F responsive genes. Genes Dev 11: 1447–1463.
Joaquin M, Watson RJ . (2003). Cell cycle regulation by the B-Myb transcription factor. Cell Mol Life Sci 60: 2389–2401.
Lam EW, Robinson C, Watson RJ . (1992). Characterization and cell cycle-regulated expression of mouse B-myb. Oncogene 7: 1885–1890.
Lam EW-F, Watson RJ . (1993). An E2F-binding site mediates cell-cycle regulated repression of mouse B-myb transcription. EMBO J 12: 2705–2713.
Lane S, Farlie P, Watson R . (1997). B-Myb function can be markedly enhanced by cyclin A-dependent kinase and protein truncation. Oncogene 14: 2445–2453.
Liu DX, Greene LA . (2001). Regulation of neuronal survival and death by E2F-dependent gene repression and derepression. Neuron 32: 425–438.
Maehara K, Yamakoshi K, Ohtani N, Kubo Y, Takahashi A, Arase S et al. (2005). Reduction of total E2F/DP activity induces senescence-like cell cycle arrest in cancer cells lacking functional pRB and p53. J Cell Biol 168: 553–560.
Margueron R, Trojer P, Reinberg D . (2005). The key to development: interpreting the histone code? Curr Opin Genet Dev 15: 163–176.
Morgenstern JP, Land H . (1990). Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res 18: 3587–3596.
Nagy A, Gertsenstein M, Vintersten K, Behringer R . (2003). Manipulating the Mouse Genome; a Laboratory Manual, 3rd edn. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, New York.
Narita M, Nunez S, Heard E, Lin AW, Hearn SA, Spector D et al. (2003). Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113: 703–716.
Nielsen SJ, Schneider R, Bauer UM, Bannister AJ, Morrison A, O'Carroll D et al. (2001). Rb targets histone H3 methylation and HP1 to promoters. Nature 412: 561–565.
Rayman JB, Takahashi Y, Dannenberg JH, Catchpole S, Watson R, te Riele H et al. (2002). E2F mediates cell cycle-dependent transcriptional repression in vivo by recruitment of specific co-repressor complex. Genes Dev 16: 933–947.
Robinson C, Light Y, Groves R, Mann D, Marais R, Watson R . (1996). Cell-cycle regulation of B-Myb protein expression: specific phosphorylation during the S phase of the cell cycle. Oncogene 12: 1855–1864.
Rowland BD, Denissov SG, Douma S, Stunnenberg HG, Bernards R, Peeper DS . (2002). E2F transcriptional repressor complexes are critical downstream targets of p19(ARF)/p53-induced proliferative arrest. Cancer Cell 2: 55–65.
Sala A, Kundu M, Casella I, Engelhard A, Calabretta B, Grasso L et al. (1997). Activation of human B-MYB by cyclins. Proc Natl Acad Sci USA 94: 532–536.
Sitzmann J, Noben-Trauth K, Kamano H, Klempnauer K-H . (1996). Expression of B-Myb during mouse embryogenesis. Oncogene 12: 1889–1894.
Takahashi Y, Rayman JB, Dynlacht BD . (2000). Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression. Genes Dev 14: 804–816.
Todaro GJ, Green H . (1963). Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J Cell Biol 17: 299–313.
Wells J, Boyd KE, Fry CJ, Bartley SM, Farnham PJ . (2000). Target gene specificity of E2F and pocket protein family members in living cells. Mol Cell Biol 20: 5797–5807.
Ziebold U, Bartsch O, Marais R, Ferrari S, Klempnauer K-H . (1997). Phosphorylation and activation of B-Myb by cyclin A-Cdk2. Curr Biol 7: 253–260.
Zwicker J, Liu N, Engeland K, Lucibello FC, Müller R . (1996). Cell cycle regulation of E2F site occupation in vivo. Science 271: 1595–1597.
Acknowledgements
We thank Paloma Garcia, Nikla Emambokus, Gordon Peters, Xin Lu and Laura O'Neill for reagents and valuable advice. This work was supported by project grants from Association for International Cancer Research (to RJW and JF) and Biotechnology and Biological Sciences Research Council (to RJW).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tavner, F., Frampton, J. & Watson, R. Targeting an E2F site in the mouse genome prevents promoter silencing in quiescent and post-mitotic cells. Oncogene 26, 2727–2735 (2007). https://doi.org/10.1038/sj.onc.1210087
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1210087
Keywords
This article is cited by
-
Prime editing in mice reveals the essentiality of a single base in driving tissue-specific gene expression
Genome Biology (2021)
-
Characterization of the zinc finger proteins ZMYM2 and ZMYM4 as novel B-MYB binding proteins
Scientific Reports (2020)
-
Human papilloma virus E7 oncoprotein abrogates the p53-p21-DREAM pathway
Scientific Reports (2017)
-
An important role for Myb-MuvB and its target gene KIF23 in a mouse model of lung adenocarcinoma
Oncogene (2017)
-
Cyclin F suppresses B-Myb activity to promote cell cycle checkpoint control
Nature Communications (2015)